[article] 
inMÉDECINE NUCLÉAIRE > 39, n° 1 (2015) . - 18-25

Titre :	PET imaging with 68gallium labelled somatostatin analogues in the evaluation of neuroendocrine tumours (NETs)
Type de document :	texte imprimé
Auteurs :	C. Ansquer, Auteur ; F. Tenenbaum, Auteur ; F. Montravers, Auteur ; D. Taïeb, Auteur
Année de publication :	2015
Article en page(s) :	18-25
Langues :	Français (fre)
Mots-clés :	gallium  marquage isotopique  Syndrome de cushing  tumeurs neuro-endocrines  récepteurs de la somatostatine
Résumé :	Neuroendocrine tumours (NETs) are rare tumours arising from cells of the nervous and endocrine systems. Since the 1990's, the use of somatostatin analogues (SSTa) imaging for NETs evaluation has allowed a better understanding of these neoplasms. Recent 68gallium labelled somatostatin analogues with higher affinity for somatostatin receptors are now available for PET/CT imaging of NETs, leading to new imaging protocols for patient care. Three new analogues (DOTATOC, DOTANOC, DOTATATE) were superior to OctreoScan®, and conventional imaging for lesion detection. In this article, recent publications on the diagnostic and care of gastroenteropancreatic (GEP) tumours, pheochromocytomas/paragangliomas (PPGLs), unknown primary tumours, medullary thyroid carcinomas (MTC), Merkel tumours and Cushing syndrome with ectopic ACTH hypersecretion are reviewed.
Permalink :	http://cdocs.helha.be/pmbgilly/opac_css/index.php?lvl=notice_display&id=33740

[article] PET imaging with 68gallium labelled somatostatin analogues in the evaluation of neuroendocrine tumours (NETs) [texte imprimé] / C. Ansquer, Auteur ; F. Tenenbaum, Auteur ; F. Montravers, Auteur ; D. Taïeb, Auteur . - 2015 . - 18-25.
Langues : Français (fre)
in MÉDECINE NUCLÉAIRE > 39, n° 1 (2015) . - 18-25

Mots-clés :	gallium  marquage isotopique  Syndrome de cushing  tumeurs neuro-endocrines  récepteurs de la somatostatine
Résumé :	Neuroendocrine tumours (NETs) are rare tumours arising from cells of the nervous and endocrine systems. Since the 1990's, the use of somatostatin analogues (SSTa) imaging for NETs evaluation has allowed a better understanding of these neoplasms. Recent 68gallium labelled somatostatin analogues with higher affinity for somatostatin receptors are now available for PET/CT imaging of NETs, leading to new imaging protocols for patient care. Three new analogues (DOTATOC, DOTANOC, DOTATATE) were superior to OctreoScan®, and conventional imaging for lesion detection. In this article, recent publications on the diagnostic and care of gastroenteropancreatic (GEP) tumours, pheochromocytomas/paragangliomas (PPGLs), unknown primary tumours, medullary thyroid carcinomas (MTC), Merkel tumours and Cushing syndrome with ectopic ACTH hypersecretion are reviewed.
Permalink :	http://cdocs.helha.be/pmbgilly/opac_css/index.php?lvl=notice_display&id=33740